Rare diseases
Investigational molecules
Locations
Back to France1 094 clinical trials in Montpellier, France across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer Not Treatable by Surgery
FranceStudy on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin
FranceStudy on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma
FranceStudy of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer
FranceStudy on Preserving the Voice Box in Patients with Advanced Laryngeal or Hypopharyngeal Cancer Using Cisplatin, Fluorouracil, and Docetaxel Therapy
FranceStudy on Early Temozolomide Treatment for Adults with Glioblastoma
FranceStudy on the Effects of Methylprednisolone and Sodium Chloride in Patients Undergoing Surgery for Digestive Cancer
FranceStudy on the Effects of Etavopivat for Patients Aged 12-65 with Sickle Cell Disease
FranceStudy of Lecanemab (BAN2401) Treatment in People with Early Alzheimer's Disease: Testing Safety and Effectiveness Over 18 Months
FranceStudy on Vemurafenib for Patients with Advanced Cancers with BRAF Gene Changes
FranceStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
FranceStudy on the Effectiveness of Mesenchymal Stromal Cells in Children with Steroid-Refractory Acute Graft-Versus-Host Disease
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on head and neck cancer, bladder cancer, and mantle cell lymphoma. Studies evaluate combination therapies and novel treatment approaches for improved patient outcomes.
Research includes evaluation of immunotherapy combinations and targeted molecular approaches.
Studies examining innovative treatments for Crohn's disease, multiple sclerosis, and systemic sclerosis. Research focuses on novel therapeutic approaches and treatment optimization.
Trials aim to improve disease management and patient quality of life.
Investigating treatments for achondroplasia, pyruvate dehydrogenase deficiency, and thyroid eye disease. Focus on developing targeted therapies for these uncommon conditions.
Research aims to address unmet medical needs in rare disease populations.
Clinical trials evaluating vaccines for cytomegalovirus, yellow fever, and HPV prevention. Studies focus on immunization effectiveness and safety profiles.
Research emphasizes disease prevention and public health improvement.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
